Premenstrual syndrome.
Wyatt
Katrina
K
Exeter and North Devon Research and Development Support Unit, Exeter, UK.
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D003613:Danazol / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives; D006801:Humans; D011293:Premenstrual Syndrome / Q000188:drug therapy / Q000628:therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D014151:Anti-Anxiety Agents; D003613:Danazol; D004232:Diuretics; D004965:Estrogen Antagonists; D007987:Gonadotropin-Releasing Hormone; D017367:Selective Serotonin Reuptake Inhibitors